21-Feb-2025
Trending stocks in a bearish week for Wall Street
Seeking Alpha News (Sat, 22-Feb 12:38 PM ET)
Catalyst Watch: Nvidia earnings, Amazon product event, PayPal Investor Day and Buffett's letter
Seeking Alpha News (Fri, 21-Feb 3:00 PM ET)
Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA
TipRanks (Fri, 21-Feb 12:59 PM ET)
Why Is HIMS Stock Dropping Today?
TipRanks (Fri, 21-Feb 12:22 PM ET)
FDA to spare compounders as Novo Nordisk’s Ozempic supply begins to improve
Seeking Alpha News (Fri, 21-Feb 10:55 AM ET)
Stocks with the largest increases and decreases in short interest since the elections – Goldman
Seeking Alpha News (Fri, 21-Feb 10:50 AM ET)
Hims & Hers gains peptide facility; shares tumble on semaglutide shortage end
Seeking Alpha News (Fri, 21-Feb 9:33 AM ET)
Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage
Seeking Alpha News (Fri, 21-Feb 9:26 AM ET)
Hims & Hers Acquires US-based Peptide Facility
Business Wire (Fri, 21-Feb 9:00 AM ET)
TipRanks (Fri, 21-Feb 8:10 AM ET)
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Hims & Hers Health Class A trades on the NYSE stock market under the symbol HIMS.
As of February 21, 2025, HIMS stock price declined to $49.28 with 79,072,820 million shares trading.
HIMS has a market cap of $10.77 billion. This is considered a Large Cap stock.
Last quarter Hims & Hers Health Class A reported $402 million in Revenue and $.32 earnings per share. This beat revenue expectation by $19 million and exceeded earnings estimates by $.28.
In the last 3 years, HIMS traded as high as $72.98 and as low as $2.72.
The top ETF exchange traded funds that HIMS belongs to (by Net Assets): IJR, IWM, VTI, VB, IJT.
HIMS has outperformed the market in the last year with a price return of +423.7% while the SPY ETF gained +22.1%. HIMS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +104.1% and +15.8%, respectively, while the SPY returned +1.4% and -0.1%, respectively.
HIMS support price is $61.64 and resistance is $71.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIMS shares will trade within this expected range on the day.